On the Fly: Christine Munz from Leica Biosystems to the top of Eppendorf

August 30, 2024. The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the company as planned.

“We are very pleased that we were able to win Dr. Munz for Eppendorf and the CEO position,” said Philipp von Loeper, the Chairman of the Supervisory Board at Eppendorf SE. “On behalf of the entire Supervisory Board, I would also like to thank Dr. Plüster for his tremendous commitment to the company with which he has worked as CEO in the past few months. After serving more than 10 years on the Management Board of Eppendorf, he demonstrated once again his enormous dedication to the company. We are really pleased that he will remain at Eppendorf and assume another responsible position within the company.”

With Dr. Christine Munz Eppendorf will have a strong international experienced CEO, said von Loeper and added: “She is a proven and highly skilled manager with many years of experience in the life science industry. Working together with the global management team, Dr. Munz will continue to drive forward Eppendorf’s successful activities and expand them in a targeted manner.”

Source: Eppendorf Group SE & Co. KG

Biographical Sketch

Added By B2Bioworld

Christine-Luise Munz (born Romania 1971) comes from Leica Biosystems Deutschland GmbH part of U.S. Danaher Corporation. She studied biology at Heidelberg and obtained her doctorate (Dr. rer. nat.) in molecular biology in 2000 working at the German Cancer Research Centre DKFZ. Thereafter she joined Carl Roth, a trader of lab supplies. A year later she joined Roche Diagnostics at Mannheim for the next fourteen years with increasing responsibility, lately as Global Product Manager for the company’s Lifecycler Products. In August 2020 she moved on to Leica Biosystems Deutschland to become its Executive Managing Director (“Geschäftsführer”) with added responsibility for Leica’s Nussloch subsidiary where she is still registered with both companies as "Geschäftsführer" until today.  October 1, she will move into her new position as CEO of Eppendorf.

She also provides general advice as member of the Board of Trustees of the Max-Planck-Institute for Nuclear Physics at Heidelberg. Eds.

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld\'s sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.

Back to section

masthead | contact | terms & disclaimer | data & privacy | © B2Bioworld 2024